Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Enzymatica

1.77 SEK

+1.15 %

Less than 1K followers

ENZY

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus

Major Owners
Source: Millistream Market Data AB

OwnerCapitalVotes
Mats Andersson, privat och genom bolag24.3 %24.3 %
Roosgruppen AB13.6 %13.6 %
Björn Algkvist, genom Fibonacci Asset Management9.5 %9.5 %
Bengt Baron, privat och genom bolag4.4 %4.4 %
Nordnet Pensionsförsäkring AB4.2 %4.2 %
Carl och Claes Kinell, privat och genom Muirfield Invest AB2.9 %2.9 %
Tom Stendahl2.8 %2.8 %
Jan Olof Backman, genom Backman Invest AB2.8 %2.8 %
Peter Bevelin, genom Aktiebolaget Possessor2.7 %2.7 %
Ágústa Gudmundsdottir, privat och genom bolag2.2 %2.2 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.